Hongsong Yu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hongsong Yu has a total of 243 co-authors. Here are the top co-authors by number of shared publications:
Aize Kijlstra
Department of Ophthalmology, University Eye Clinic Maastricht, Maastricht, The Netherlands
28 shared publications- Peizeng Yang
Ophthalmology Medical Center The First Affiliated Hospital of Chongqing Medical University Chongqing People's Republic of China
26 shared publications Xin Wang
Institute of Basic Medical Sciences, Special Key Laboratory of Gene Detection and Therapy of Guizhou Province, Zunyi Medical University
18 shared publications- Xin Wang
School of Basic Medical Science, Special Key Laboratory of Gene Detection and Therapy of Guizhou Province, Zunyi Medical University, Zunyi 563000, China
11 shared publications Hua Li
Yongchuan Hospital, Chongqing Medical University, Chongqing, China
10 shared publicationsWenwen Wei
Department of Immunology, Special Key Laboratory of Gene Detection and Therapy of Guizhou Province, Zunyi Medical University, Zunyi, Guizhou, China
9 shared publications
Latest Publications
- Open Access
- 21 September 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (9) , 1373
Associations of ASIC2, IKZF3, and GSDMB Variants with Gestational Diabetes Mellitus and Their Interactions with Environmental Exposures Among Chinese Women
Gestational diabetes mellitus (GDM) is a common pregnancy complication associated with adverse maternal and offspring cardiometabolic outcomes. However, the combined effects of genetic susceptibility and environmental exposures on GDM risk remain unclear. We conducted a case–control study of 1564 pregnant women in China. Targeted next-generation sequencing was used to genotype ASIC2/rs12450465, IKZF3/rs2060941, and GSDMB/rs2305479. Associations of individual variants and haplotypes with GDM were evaluated, and interactions with exposure to PM2.5, O3, and monoisobutyl phthalate (MIBP) were assessed. Multiple comparisons in the primary covariate-unadjusted analyses were controlled using the Benjamini–Hochberg false discovery rate (FDR) procedure. In the overall study population, the rs12450465-rs2060941-rs2305479 T-T-T haplotype was significantly associated with GDM after FDR correction (nominal p = 0.00266, FDR-adjusted p = 0.0133, OR = 1.741, 95% CI = 1.208–2.509). Several gene–gene and gene–air pollutant interaction signals, particularly those involving O3 exposure, remained statistically significant after FDR correction in the primary covariate-unadjusted analyses. Among 289 participants with urinary MIBP measurements, the T-T-T haplotype was similarly associated with GDM (nominal p = 0.003837, FDR-adjusted p = 0.0192, OR = 2.980, 95% CI = 1.378–6.446), and additional interaction signals between this haplotype and MIBP exposure were identified. These findings suggest that gene–environment interactions may contribute to susceptibility to GDM and identify the T-T-T haplotype as a potential susceptibility marker. Nevertheless, the results, particularly those from the smaller MIBP subgroup and the covariate-unadjusted interaction analyses, require validation in larger, independent, and more diverse populations.
- 21 September 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (9) , 1373
Open AccessAssociations of ASIC2, IKZF3, and GSDMB Variants with Gestational Diabetes Mellitus and Their Interactions with Environmental Exposures Among Chinese Women
Gestational diabetes mellitus (GDM) is a common pregnancy complication associated with adverse maternal and offspring cardiometabolic outcomes. However, the combined effects of genetic susceptibility and environmental exposures on GDM risk remain unclear. We conducted a case–control study of 1564 pregnant women in China. Targeted next-generation sequencing was used to genotype ASIC2/rs12450465, IKZF3/rs2060941, and GSDMB/rs2305479. Associations of individual variants and haplotypes with GDM were evaluated, and interactions with exposure to PM2.5, O3, and monoisobutyl phthalate (MIBP) were assessed. Multiple comparisons in the primary covariate-unadjusted analyses were controlled using the Benjamini–Hochberg false discovery rate (FDR) procedure. In the overall study population, the rs12450465-rs2060941-rs2305479 T-T-T haplotype was significantly associated with GDM after FDR correction (nominal p = 0.00266, FDR-adjusted p = 0.0133, OR = 1.741, 95% CI = 1.208–2.509). Several gene–gene and gene–air pollutant interaction signals, particularly those involving O3 exposure, remained statistically significant after FDR correction in the primary covariate-unadjusted analyses. Among 289 participants with urinary MIBP measurements, the T-T-T haplotype was similarly associated with GDM (nominal p = 0.003837, FDR-adjusted p = 0.0192, OR = 2.980, 95% CI = 1.378–6.446), and additional interaction signals between this haplotype and MIBP exposure were identified. These findings suggest that gene–environment interactions may contribute to susceptibility to GDM and identify the T-T-T haplotype as a potential susceptibility marker. Nevertheless, the results, particularly those from the smaller MIBP subgroup and the covariate-unadjusted interaction analyses, require validation in larger, independent, and more diverse populations.
- Open Access
- 16 June 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1827384
Decoding autoimmune disease with single-cell immune repertoire and transcriptome sequencing: mechanisms and therapeutic opportunities
Autoimmune diseases result from a breakdown of immune tolerance, driving the aberrant activation and clonal expansion of self-reactive T and B cells. Progress has been limited by the inability to link clonal identity to functional states at single-cell resolution. Single-cell T- and B-cell receptor sequencing (scTCR/BCR-seq) now bridges this gap by simultaneously recovering paired TCR (α/β) and BCR (heavy/light) chains and gene-expression profiles, enabling direct coupling of clonotypes to cellular function and tissue trafficking. This shift from population-level averaging to clonal-resolution analysis, particularly when integrated with multi-omics, has yielded substantial insights. Mechanistically, scTCR/BCR-seq identifies tissue-homing, putatively pathogenic clones and resolves somatic hypermutation, class-switch recombination, and T-B cell interaction networks, thereby delineating the clonal basis of disease heterogeneity. Clinically, it enables tracking of clonal dynamics to inform prognosis and to predict responses to therapies such as anti-CD20 or BAFF-targeted agents. For therapeutic development, reconstructing autoantibodies from BCR clones and mapping epitopes through TCR analysis provide a foundation for antigen-specific tolerance strategies. This review synthesizes scTCR/BCR-seq methodologies and systematically charts these advances and discusses current challenges and future directions toward precision subtyping, biomarker development, and novel immunotherapies in autoimmune disease.
- 16 June 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1827384
Open AccessDecoding autoimmune disease with single-cell immune repertoire and transcriptome sequencing: mechanisms and therapeutic opportunities
Autoimmune diseases result from a breakdown of immune tolerance, driving the aberrant activation and clonal expansion of self-reactive T and B cells. Progress has been limited by the inability to link clonal identity to functional states at single-cell resolution. Single-cell T- and B-cell receptor sequencing (scTCR/BCR-seq) now bridges this gap by simultaneously recovering paired TCR (α/β) and BCR (heavy/light) chains and gene-expression profiles, enabling direct coupling of clonotypes to cellular function and tissue trafficking. This shift from population-level averaging to clonal-resolution analysis, particularly when integrated with multi-omics, has yielded substantial insights. Mechanistically, scTCR/BCR-seq identifies tissue-homing, putatively pathogenic clones and resolves somatic hypermutation, class-switch recombination, and T-B cell interaction networks, thereby delineating the clonal basis of disease heterogeneity. Clinically, it enables tracking of clonal dynamics to inform prognosis and to predict responses to therapies such as anti-CD20 or BAFF-targeted agents. For therapeutic development, reconstructing autoantibodies from BCR clones and mapping epitopes through TCR analysis provide a foundation for antigen-specific tolerance strategies. This review synthesizes scTCR/BCR-seq methodologies and systematically charts these advances and discusses current challenges and future directions toward precision subtyping, biomarker development, and novel immunotherapies in autoimmune disease.
- Open Access
- 8 June 2026
- Published by Elsevier in SSRN Electronic Journal
Single-Cell Transcriptomics Maps the Splenic Immune Landscape in a Mouse Model of Graves' Disease
Background: Graves' disease (GD) is an organ-specific autoimmune disorder driven by thyroid-stimulating hormone receptor (TSHR) autoantibodies. However, whether and how the splenic immune landscape orchestrates systemic autoimmunity remains poorly understood.Methods: We established an Ad‑TSHR289‑induced GD mouse model and performed single‑cell RNA sequencing (scRNA‑seq) on spleens from three GD mice and three controls. Key findings were validated by flow cytometry, multicolour immunofluorescence and RT‑qPCR.Findings: We profiled 48,650 high‑quality cells and delineated 37 clusters corresponding to 25 distinct cell types, including a novel macrophage subpopulation defined by Marco⁺Pla2g2d⁺ expression. This subset exhibited Srebf2‑driven lipid metabolic reprogramming and was validated by immunofluorescence. T follicular helper 2 (Tfh2) cells were significantly expanded in GD spleens and overexpressed Eno1 and Bcl2. Cell‑cell interaction analysis revealed a GD‑specific communication axis between Tfh1 cells and germinal centre B cells vi:a IFN‑γ and SEMA4 signalling. Interpretation: To our knowledge, this work provides the first comprehensive single‑cell transcriptomic map of the GD mouse spleen, revealing immune‑cell dynamics, a novel macrophage subset, and key pathogenic T‑B interactions. These findings offer a framework for precision therapeutic targeting in GD.
- 8 June 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessSingle-Cell Transcriptomics Maps the Splenic Immune Landscape in a Mouse Model of Graves' Disease
Background: Graves' disease (GD) is an organ-specific autoimmune disorder driven by thyroid-stimulating hormone receptor (TSHR) autoantibodies. However, whether and how the splenic immune landscape orchestrates systemic autoimmunity remains poorly understood.Methods: We established an Ad‑TSHR289‑induced GD mouse model and performed single‑cell RNA sequencing (scRNA‑seq) on spleens from three GD mice and three controls. Key findings were validated by flow cytometry, multicolour immunofluorescence and RT‑qPCR.Findings: We profiled 48,650 high‑quality cells and delineated 37 clusters corresponding to 25 distinct cell types, including a novel macrophage subpopulation defined by Marco⁺Pla2g2d⁺ expression. This subset exhibited Srebf2‑driven lipid metabolic reprogramming and was validated by immunofluorescence. T follicular helper 2 (Tfh2) cells were significantly expanded in GD spleens and overexpressed Eno1 and Bcl2. Cell‑cell interaction analysis revealed a GD‑specific communication axis between Tfh1 cells and germinal centre B cells vi:a IFN‑γ and SEMA4 signalling. Interpretation: To our knowledge, this work provides the first comprehensive single‑cell transcriptomic map of the GD mouse spleen, revealing immune‑cell dynamics, a novel macrophage subset, and key pathogenic T‑B interactions. These findings offer a framework for precision therapeutic targeting in GD.
- Open Access
- 22 April 2026
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 14, 1725802
CDKN2A/2B gene variants and gene-environment interactions increase the risk of gestational diabetes mellitus in Chinese women
Introduction: This study investigates the association between the cyclin-dependent kinase inhibitor 2A/2B ( CDKN2A/2B ) gene and gestational diabetes mellitus (GDM) in Chinese women, with a focus on potential gene-environment interactions. Methods: A case-control study was conducted with 1,566 pregnant women from Beijing, Wuhan, and Zunyi, China. Blood samples were analyzed using targeted next-generation sequencing. Logistic regression was applied to examine the relationship between gene polymorphisms, environmental exposures, and GDM. Gene-environment interactions were assessed using Excel tools developed by Knol and Andersson et al. Results: Genetic analysis revealed significant associations between two of the three loci: rs23832080 ( P = 0.002, OR = 0.801) and rs10811661 (P = 0.00055, OR = 0.746), and GDM. Haplotype analysis showed that haplotypes of these loci were correlated with GDM (AGC: P = 0.002, OR = 0.784; AAT: P = 0.024, OR = 1.183; GAT: P = 0.043, OR = 1.247). Environmental exposure analysis indicated that ozone (O 3 ) and PM 2.5 were associated with GDM. Interaction analysis revealed that the wild-type alleles of rs2383208 and rs10811661 interacted with O 3 , increasing the risk of GDM, while the wild-type allele of rs10811661 also interacted with PM 2.5 , further elevating GDM risk. Conclusion: CDKN2A/2B gene polymorphisms, haplotypes, environmental exposure to O 3 and PM 2.5 , and gene-environment interactions contribute to an increased risk of GDM in Chinese women. Trial Registration: Chinese Clinical Trial Registry, chictr.org.cn , ChiCTR2000029178.
- 22 April 2026
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 14, 1725802
Open AccessCDKN2A/2B gene variants and gene-environment interactions increase the risk of gestational diabetes mellitus in Chinese women
Introduction: This study investigates the association between the cyclin-dependent kinase inhibitor 2A/2B ( CDKN2A/2B ) gene and gestational diabetes mellitus (GDM) in Chinese women, with a focus on potential gene-environment interactions. Methods: A case-control study was conducted with 1,566 pregnant women from Beijing, Wuhan, and Zunyi, China. Blood samples were analyzed using targeted next-generation sequencing. Logistic regression was applied to examine the relationship between gene polymorphisms, environmental exposures, and GDM. Gene-environment interactions were assessed using Excel tools developed by Knol and Andersson et al. Results: Genetic analysis revealed significant associations between two of the three loci: rs23832080 ( P = 0.002, OR = 0.801) and rs10811661 (P = 0.00055, OR = 0.746), and GDM. Haplotype analysis showed that haplotypes of these loci were correlated with GDM (AGC: P = 0.002, OR = 0.784; AAT: P = 0.024, OR = 1.183; GAT: P = 0.043, OR = 1.247). Environmental exposure analysis indicated that ozone (O 3 ) and PM 2.5 were associated with GDM. Interaction analysis revealed that the wild-type alleles of rs2383208 and rs10811661 interacted with O 3 , increasing the risk of GDM, while the wild-type allele of rs10811661 also interacted with PM 2.5 , further elevating GDM risk. Conclusion: CDKN2A/2B gene polymorphisms, haplotypes, environmental exposure to O 3 and PM 2.5 , and gene-environment interactions contribute to an increased risk of GDM in Chinese women. Trial Registration: Chinese Clinical Trial Registry, chictr.org.cn , ChiCTR2000029178.
- 16 January 2026
- Published by Elsevier in Human Immunology
- Vol. 87 (3) , 111659
Association of NLRC3 gene polymorphism with Graves’ disease susceptibility in a Southwest Chinese Han population
- 16 January 2026
- Published by Elsevier in Human Immunology
- Vol. 87 (3) , 111659
Association of NLRC3 gene polymorphism with Graves’ disease susceptibility in a Southwest Chinese Han population
- Open Access
- 7 December 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (24) , 11823
Epigenetic Mechanisms in Autoimmune Thyroid Diseases: Bridging Research and Clinical Applications
Autoimmune thyroid disease (AITD) exemplifies an organ-specific autoimmune disorder, including Hashimoto’s thyroiditis (HT) and Graves’ disease (GD). HT is characterized by hypothyroidism, whereas GD primarily presents as hyperthyroidism. Immunological evidence indicates that AITD pathogenesis requires both a permissive genetic background and environmental triggers to initiate and sustain disease progression. However, the exact molecular and cellular pathways through which these elements synergize to trigger and sustain autoimmune responses remain unclear. Emerging evidence suggests that epigenetic regulation serves as the key interface decoding genetic predisposition through environmental stimuli in AITD etiology. Studies show that environmental epigenetic reprogramming initiates AITD development in genetically susceptible individuals. Epigenetic regulators, including DNA methylation, histone modifications, and non-coding RNA activity, finely tune transcriptional outputs to influence disease trajectories. Beyond elucidating AITD pathogenesis, these epigenetic alterations offer clinical value as diagnostic biomarkers and modifiable therapeutic targets, facilitating precision medicine approaches from early detection to customized interventions. These epigenetic modifications not only elucidate AITD pathophysiology but also provide measurable markers for early diagnosis and molecular targets for personalized treatment strategies.
- 7 December 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (24) , 11823
Open AccessEpigenetic Mechanisms in Autoimmune Thyroid Diseases: Bridging Research and Clinical Applications
Autoimmune thyroid disease (AITD) exemplifies an organ-specific autoimmune disorder, including Hashimoto’s thyroiditis (HT) and Graves’ disease (GD). HT is characterized by hypothyroidism, whereas GD primarily presents as hyperthyroidism. Immunological evidence indicates that AITD pathogenesis requires both a permissive genetic background and environmental triggers to initiate and sustain disease progression. However, the exact molecular and cellular pathways through which these elements synergize to trigger and sustain autoimmune responses remain unclear. Emerging evidence suggests that epigenetic regulation serves as the key interface decoding genetic predisposition through environmental stimuli in AITD etiology. Studies show that environmental epigenetic reprogramming initiates AITD development in genetically susceptible individuals. Epigenetic regulators, including DNA methylation, histone modifications, and non-coding RNA activity, finely tune transcriptional outputs to influence disease trajectories. Beyond elucidating AITD pathogenesis, these epigenetic alterations offer clinical value as diagnostic biomarkers and modifiable therapeutic targets, facilitating precision medicine approaches from early detection to customized interventions. These epigenetic modifications not only elucidate AITD pathophysiology but also provide measurable markers for early diagnosis and molecular targets for personalized treatment strategies.
- Open Access
- 24 November 2025
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 23 (1) , 1343
Epigenetic modifier m⁶A methylation: insights into the pathogenesis and therapeutic potential of autoimmune diseases
N6-methyladenosine (m⁶A) methylation is a predominant form of RNA modification in eukaryotic cells. It exerts profound influence over the processing of mRNA, rRNA and tRNA, thereby playing a critical role in various biological processes, including RNA transcription, splicing, degradation, and translation regulation. The m⁶A methylation significantly affects cell fate and signal transduction pathways by regulating gene expression. Notably, aberrant m⁶A modification is strongly associated with the onset and progression of autoimmune diseases. Emerging evidence indicates that these regulatory factors display disease-specific expression patterns and functional roles, influencing immune-cell differentiation and effector functions, inflammatory responses, and tissue injury. This article provides an overview of recent advances in m⁶A biology in autoimmunity and discusses their implications for diagnosis and therapeutic intervention. Clinical trial number Not applicable.
- 24 November 2025
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 23 (1) , 1343
Open AccessEpigenetic modifier m⁶A methylation: insights into the pathogenesis and therapeutic potential of autoimmune diseases
N6-methyladenosine (m⁶A) methylation is a predominant form of RNA modification in eukaryotic cells. It exerts profound influence over the processing of mRNA, rRNA and tRNA, thereby playing a critical role in various biological processes, including RNA transcription, splicing, degradation, and translation regulation. The m⁶A methylation significantly affects cell fate and signal transduction pathways by regulating gene expression. Notably, aberrant m⁶A modification is strongly associated with the onset and progression of autoimmune diseases. Emerging evidence indicates that these regulatory factors display disease-specific expression patterns and functional roles, influencing immune-cell differentiation and effector functions, inflammatory responses, and tissue injury. This article provides an overview of recent advances in m⁶A biology in autoimmunity and discusses their implications for diagnosis and therapeutic intervention. Clinical trial number Not applicable.
- Open Access
- 15 September 2025
- Published by American Chemical Society (ACS) in Environment & Health
- Vol. 4 (1) , 28-39
The China Birth Cohort-Environmental and Genetic Factors (CBC-EG) Study: Design, Aims, Protocol, Findings, and Prospects
Early life, including the embryonic period, is particularly vulnerable to environmental exposures. Previous studies have largely focused on the relationship between individual environmental factors and population health. In reality, individuals are exposed to multiple environmental factors, which together form an “exposome” that reflects the environmental influences on human health. Exposome-based analyses utilizing biological samples have been conducted in various countries to assess the impacts of environmental endocrine disruptors and other pollutants on maternal and fetal health during pregnancy, particularly in developed countries. However, large-scale cohort studies that comprehensively cover major maternal and fetal diseases during pregnancy to explore the environmental and genetic interactions affecting maternal and fetal health are still lacking in China. Currently, environmental exposure assessment and biomarker measurement are particularly complex, given the challenges posed by handling mixed exposure effects and the hidden threats posed by emerging contaminants. The China Birth Cohort-Environmental Genetic Factors (CBC-EG) study was established as a large, multicenter cohort study spanning 14 cities across China. A total of 101,437 pregnant women were recruited between 2013 and 2022. The objectives of this cohort study include analyzing the effects of environmental exposure levels and behavioral factors, monitored through external exposure assessments, on embryonic development and pregnancy-related diseases. Additionally, the study aims to explore the impact of environmental pollutants, monitored through internal exposure assessments, on embryonic development and pregnancy outcomes. A key focus of this research is to investigate the potential threats posed by emerging contaminants to maternal and fetal health, as well as to uncover environmental and genetic interactions and identify susceptibility loci.
- 15 September 2025
- Published by American Chemical Society (ACS) in Environment & Health
- Vol. 4 (1) , 28-39
Open AccessThe China Birth Cohort-Environmental and Genetic Factors (CBC-EG) Study: Design, Aims, Protocol, Findings, and Prospects
Early life, including the embryonic period, is particularly vulnerable to environmental exposures. Previous studies have largely focused on the relationship between individual environmental factors and population health. In reality, individuals are exposed to multiple environmental factors, which together form an “exposome” that reflects the environmental influences on human health. Exposome-based analyses utilizing biological samples have been conducted in various countries to assess the impacts of environmental endocrine disruptors and other pollutants on maternal and fetal health during pregnancy, particularly in developed countries. However, large-scale cohort studies that comprehensively cover major maternal and fetal diseases during pregnancy to explore the environmental and genetic interactions affecting maternal and fetal health are still lacking in China. Currently, environmental exposure assessment and biomarker measurement are particularly complex, given the challenges posed by handling mixed exposure effects and the hidden threats posed by emerging contaminants. The China Birth Cohort-Environmental Genetic Factors (CBC-EG) study was established as a large, multicenter cohort study spanning 14 cities across China. A total of 101,437 pregnant women were recruited between 2013 and 2022. The objectives of this cohort study include analyzing the effects of environmental exposure levels and behavioral factors, monitored through external exposure assessments, on embryonic development and pregnancy-related diseases. Additionally, the study aims to explore the impact of environmental pollutants, monitored through internal exposure assessments, on embryonic development and pregnancy outcomes. A key focus of this research is to investigate the potential threats posed by emerging contaminants to maternal and fetal health, as well as to uncover environmental and genetic interactions and identify susceptibility loci.
- Open Access
Gut Microbiota and Metabolites: Biomarkers and Therapeutic Targets for Diabetes Mellitus and Its Complications
Diabetes mellitus (DM) is a complex metabolic disease characterized by significantly elevated blood glucose levels as a result of dysfunctional or impaired pancreatic β-cells, leading to insulin deficiency. This condition can result in severe complications, including cardiovascular diseases, kidney failure, vision impairment, and nerve damage. Currently available anti-diabetic drugs do not fully prevent the progression of these complications. Moreover, they often have significant side effects. The gut microbiota plays a crucial role in influencing diet, energy metabolism, and blood glucose levels. Research shows a strong link between microbiota dysbiosis and DM, as well as the severity of its complications. Commensal bacteria can help manage blood glucose levels, reduce inflammation, regulate metabolism, and enhance the gut barrier. Conversely, opportunistic pathogens can worsen insulin resistance, promote metabolic disorders, disrupt gut integrity, and affect appetite and weight. This article describes the characteristics of gut microbiota in various types of DM and explores the role of the “gut microbiota–metabolite–signaling pathway” axis in DM and its complications. In addition, it highlights the therapeutic potential of traditional Chinese medicine and dietary interventions through modulation of the gut microbiota and metabolites. The aim is to provide comprehensive evidence supporting the integration of TCM dietary therapy, targeted dietary strategies, and specific probiotics as alternative and complementary therapies for DM and its complications.
Open AccessGut Microbiota and Metabolites: Biomarkers and Therapeutic Targets for Diabetes Mellitus and Its Complications
Diabetes mellitus (DM) is a complex metabolic disease characterized by significantly elevated blood glucose levels as a result of dysfunctional or impaired pancreatic β-cells, leading to insulin deficiency. This condition can result in severe complications, including cardiovascular diseases, kidney failure, vision impairment, and nerve damage. Currently available anti-diabetic drugs do not fully prevent the progression of these complications. Moreover, they often have significant side effects. The gut microbiota plays a crucial role in influencing diet, energy metabolism, and blood glucose levels. Research shows a strong link between microbiota dysbiosis and DM, as well as the severity of its complications. Commensal bacteria can help manage blood glucose levels, reduce inflammation, regulate metabolism, and enhance the gut barrier. Conversely, opportunistic pathogens can worsen insulin resistance, promote metabolic disorders, disrupt gut integrity, and affect appetite and weight. This article describes the characteristics of gut microbiota in various types of DM and explores the role of the “gut microbiota–metabolite–signaling pathway” axis in DM and its complications. In addition, it highlights the therapeutic potential of traditional Chinese medicine and dietary interventions through modulation of the gut microbiota and metabolites. The aim is to provide comprehensive evidence supporting the integration of TCM dietary therapy, targeted dietary strategies, and specific probiotics as alternative and complementary therapies for DM and its complications.
- 31 January 2025
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 267, 108807
Single-cell RNA sequencing in autoimmune diseases: New insights and challenges
- 31 January 2025
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 267, 108807
Single-cell RNA sequencing in autoimmune diseases: New insights and challenges